Opternative Announces Ability to Route Online Vision Test Results

CHICAGO, September 24, 2018 (Newswire.com) - Opternative, Inc., a healthcare technology company, announced today the ability to route a patient’s online vision test results from its platform to a portal where designated doctors can review and dispense prescriptions for their own patients.

Instead of Opternative’s network of doctors reviewing all patient results, eye care providers and eyewear retailers who offer the online vision test can identify the doctor or doctors to review the patient’s results. Designated doctors are then able to determine the recommended next step for each patient based on the results, a renewed prescription or a comprehensive eye exam.

This new feature allows eye care providers and eyewear retailers to offer their patients the convenience of telemedicine and still remain at the forefront of their eye care.

Ayo Jimoh, CTO of Opternative

“This new feature allows eye care providers and eyewear retailers to offer their patients the convenience of telemedicine and still remain at the forefront of their eye care,” says Ayo Jimoh, CTO of Opternative. “We strive to help our partners empower their business and this technology aligns with that goal.”

About Opternative

Opternative Inc., a Chicago-based healthcare technology company, founded in 2012, creates digital eye care technologies that enable patient choice and convenience while providing doctors and retailers the ability to create awesome user experiences.

Opternative has created the most convenient and scientifically accurate digital refractive vision test. Opternative partners can now offer their clients a refractive vision test and acuity screenings from anywhere at any time.

Opternative has partnered with eye care providers and eyewear retailers across the U.S. to bring this revolutionary service to our partners’ clients. For more information on partnering with Opternative, email [email protected] or visit our partner page here.

Media Contact:

Shelby Eversole

[email protected]

Source: Opternative